Cheon E, Kim G, Park S
Sci Rep. 2025; 15(1):903.
PMID: 39762543
PMC: 11704342.
DOI: 10.1038/s41598-025-85394-4.
Huang T, Peng Q, Zhang Y, Zhu Z, Fan X
Clin Exp Med. 2024; 24(1):4.
PMID: 38231301
PMC: 10794328.
DOI: 10.1007/s10238-023-01265-0.
Kato T, Miura M, Kobayashi T, Kaneko T, Fukushima N, Suda K
J Am Heart Assoc. 2023; 12(3):e022417.
PMID: 36718857
PMC: 9973627.
DOI: 10.1161/JAHA.121.022417.
Liang S, Willis J, Dou J, Mohanty V, Huang Y, Vilar E
BMC Bioinformatics. 2022; 23(1):2.
PMID: 34983369
PMC: 8728970.
DOI: 10.1186/s12859-021-04526-5.
Thangathurai J, Kalashnikova M, Takahashi M, Shinbane J
Radiol Cardiothorac Imaging. 2021; 3(5):e200550.
PMID: 34778780
PMC: 8581589.
DOI: 10.1148/ryct.2021200550.
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.
Weng K, Cheng C, Chien K, Ger L, Huang S, Tsai K
Curr Issues Mol Biol. 2021; 43(2):485-500.
PMID: 34202375
PMC: 8929010.
DOI: 10.3390/cimb43020037.
Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease.
Nie H, Wang S, Wu Q, Xue D, Zhou W
Immun Inflamm Dis. 2020; 9(1):157-166.
PMID: 33188570
PMC: 7860604.
DOI: 10.1002/iid3.373.
Identifying Downregulation of Autophagy Markers in Kawasaki Disease.
Huang F, Huang Y, Kuo H, Li S
Children (Basel). 2020; 7(10).
PMID: 33020418
PMC: 7600284.
DOI: 10.3390/children7100166.
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
McCrindle B, Manlhiot C, Newburger J, Harahsheh A, Giglia T, Dallaire F
J Am Heart Assoc. 2020; 9(15):e016440.
PMID: 32750313
PMC: 7792232.
DOI: 10.1161/JAHA.119.016440.
Coronary Artery Dilation in Children with Febrile Exanthematous Illness without Criteria for Kawasaki Disease -An Enigmatic Disease.
Guerra V
Arq Bras Cardiol. 2019; 113(6):1119-1120.
PMID: 31800687
PMC: 7021253.
DOI: 10.36660/abc.20190730.
A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N
Pediatr Rheumatol Online J. 2019; 17(1):34.
PMID: 31269967
PMC: 6610867.
DOI: 10.1186/s12969-019-0337-2.
How Should We Classify Kawasaki Disease?.
Marrani E, Burns J, Cimaz R
Front Immunol. 2019; 9:2974.
PMID: 30619331
PMC: 6302019.
DOI: 10.3389/fimmu.2018.02974.
Coronary Artery Bypass Grafting with Arterial Grafts in Patients with Kawasaki Disease Affecting the Coronary Artery: a Korean Single-Center Study.
Jeong D, Han W, Lee Y, Kim W, Song J, Kang I
J Korean Med Sci. 2018; 33(42):e267.
PMID: 30310367
PMC: 6179982.
DOI: 10.3346/jkms.2018.33.e267.
A comparative study of established score models for coronary artery diameters in 181 healthy Korean children.
Ryu K, Yu J, Jun H, Shin E, Heo Y, Baek J
Korean J Pediatr. 2017; 60(11):373-378.
PMID: 29234361
PMC: 5725343.
DOI: 10.3345/kjp.2017.60.11.373.
Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.
Kuo H, Li S, Huang L, Huang Y
Oncotarget. 2017; 8(37):60875-60891.
PMID: 28977831
PMC: 5617391.
DOI: 10.18632/oncotarget.19650.
Distribution of Kawasaki Disease Coronary Artery Aneurysms and the Relationship to Coronary Artery Diameter.
Tsuda E, Tsujii N, Kimura K, Suzuki A
Pediatr Cardiol. 2017; 38(5):932-940.
PMID: 28321483
DOI: 10.1007/s00246-017-1599-4.
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.
Kim J, Shimizu C, Kingsmore S, Veeraraghavan N, Levy E, Ribeiro Dos Santos A
PLoS One. 2017; 12(2):e0170977.
PMID: 28151979
PMC: 5289527.
DOI: 10.1371/journal.pone.0170977.
Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
Burns J, Kone-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M
Arthritis Rheumatol. 2016; 69(2):268-276.
PMID: 27792871
PMC: 5274552.
DOI: 10.1002/art.39975.
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
Connelly M, Shimizu C, Winegar D, Shalaurova I, Pourfarzib R, Otvos J
BMC Pediatr. 2016; 16(1):151.
PMID: 27596163
PMC: 5011873.
DOI: 10.1186/s12887-016-0688-5.
Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit M
Rheumatol Int. 2016; 36(4):551-9.
PMID: 26849890
DOI: 10.1007/s00296-016-3430-6.